Evaluation of Remote Photoplethysmography to Assist Vital Signs Measure in Pediatrics

Launched by FONDATION LENVAL · Jan 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to measure vital signs, like heart rate and oxygen levels, in children without needing to touch them. The technique they are looking at is called remote photoplethysmography (rPPG), which uses a camera to analyze the colors of the skin and determine these important health signals. Until now, this method has not been tested in kids, and the researchers want to see if it works well for young patients.

To participate in this study, children must be between 3 and 17 years old, and can be visiting the hospital for any reason. Parents or guardians will need to provide written consent for their child to join. However, children with certain conditions, such as severe heart issues or those who have difficulty staying still, cannot participate. This trial is not yet recruiting participants, so there will be more information available later for families interested in taking part.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children under 18 and over 3 years of age
• • Any reason for consultation or hospitalization
• • Written and signed informed consent from one parent or the person with parental authority,
• • Membership of a social security scheme
• Exclusion Criteria:
• • Patient with a neurocognitive disorder
• • Patient in immediate vital distress,
• • Known cardiac arrhythmia,
• • Scleroderma
• • Patients suffering from pathological tremors or muscle spasms that prevent them from remaining static for the duration of the measurement.
• • Parents who do not understand and/or speak French